Study identifies factors that limit work ability of young adult cancer survivors

September 9, 2017, European Society for Medical Oncology

Factors that limit the work ability of young adult cancer survivors are reported today at the ESMO 2017 Congress in Madrid. (1)

Late side effects can occur months or years after treatment. In diagnosed with cancer in young adulthood, these late effects may interfere with career development.

The NOR-CAYACS study investigated the abilty of patients diagnosed with cancer at the ages of 19 to 39 years. (2) Patients diagnosed with melanoma, colorectal cancer, breast cancer stages I-III, non-Hodgkin lymphoma or leukaemia in 1985 to 2009, and alive in September 2015, were identified through the Cancer Registry of Norway.

Participants were mailed a questionnaire about late effects of treatment and work status, and then scored themselves from 0 (no work ability) to 10 (highest work ability) on the Work Ability Index.

A total of 1,198 participants answered the questionnaire. The median age at the time of the survey was 49 years, it was a median of 13 years since cancer treatment, and 60% had a full-time job.

A low Work Ability Index was associated with a low level of education, female sex, lymphoedema, fatigue, depression, and reduced physical quality of life and self-reported health. Non-Hodgkin lymphoma survivors had a higher risk for reduced work ability compared to the melanoma group. Treatment intensity was not associated with work ability.

"We found that psychological and physical late effects of cancer and other conditions were significantly associated with reduced work ability," said lead author Dr Cecilie Kiserud, chair, National Advisory Unit for Late Effects After Cancer Treatment, Oslo University Hospital, Oslo, Norway. "In comparison, treatment intensity and cancer type, apart from non-Hodgkin lymphoma, were not significantly related to work ability."

She concluded: "Greater awareness is needed about the fact that may be less able to work after treatment because of the late effects they might experience."

Commenting on the study, Professor Gilles Vassal, Director of Clinical Research, Gustave Roussy, Villejuif, France, and Past President of the European Society for Paediatric Oncology (SIOPE), said: "Around 80% of young people with cancer can be cured, but the treatments are intensive and two-thirds of survivors have long-term physical and psychological consequences. This study shows that the psychological and somatic effects of treatment are associated with reduced , rather than the cancer itself."

"Young cancer survivors should be informed about potential toxicities and monitored to minimise the severity of long-term sequelae," he added. "Prospective clinical trials are needed to find treatments that lower the risk of late toxicity without jeopardising the probability of cure."

A second study presented at the ESMO 2017 Congress and published online in ESMO Open (3) has revealed that more than two-thirds (67%) of healthcare providers treating adolescents and with cancer in Europe have no access to specialised centres. (4) The gap in care was more pronounced in Eastern and Southern Europe compared to Western and Northern Europe.

The finding comes from a survey on the status of care and research in these patients, conducted by the joint ESMO/SIOPE working group on adolescents and young adults with cancer. A link to an online survey was sent to members of both societies and several European oncology groups. Of 323 responses, 266 were from Europe and these results are reported at the ESMO 2017 Congress.

More than two-thirds (67%) of health professionals had no access to services specialised in managing the late effects of cancer in this patient group. A similar proportion (69%) were not aware of research in their country in this age group, which has multiple unmet needs.

Most of the respondents were able to refer young patients to professional psychological support and specialised social workers. Nearly half had access to an age-specialised nurse. Overall, 38% of respondents said young cancer patients had no access to fertility specialists, rising to 76% in Eastern Europe. Respondents wanted education on how to advance the care provided to young patients with cancer, address the late effects of , prevent second cancers, and improve molecular profiling of tumours developed in young individuals.

Lead author Dr Emmanouil Saloustros, consultant medical oncologist, General Hospital of Heraklion 'Venizelio', Heraklion, Crete, Greece, said: "The survey found gaps and disparities in cancer care for adolescents and young adults across Europe. Improving care through education and research in this age group is a growing priority for ESMO and SIOPE."

Commenting on the study, Vassal said: "These patients have specific needs that are not covered by paediatric or general oncology centres or classical medical oncology centres, and this survey shows that most do not have access to the recommended special care. Countries without these services can look at existing examples - such as in the UK and France - to build teams equipped to improve survival and survivorship for adolescents and young adults with cancer."

Further studies will be presented at the ESMO 2017 Congress on the availability of paediatric radiation therapy in Europe (5), productivity in patients with advanced gastric cancer (6), and fertility in BRCA mutant breast cancer (7).

Explore further: Some stroke survivors may have underlying cancer

More information: References:

1 Abstract 1110PD_PR 'Factors associated with reduced work ability in a nation-wide cohort of long-term cancer survivors treated in young adulthood (19-39 years) - the NOR-CAYACS study' will be presented by Dr Cecilie Kiserud during the Poster Discussion session on 'Public health policy and health economics' on Saturday, 9 September 2017, 16:30 to 17:45 (CEST) in Tarragona Auditorium.

2 NOR-CAYACS is a sub study of a larger investigation on cancer survivorship in young adults in Norway.

3 The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey. ESMO Open 2017;0:e000252. DOI: 10.1136/esmoopen-2017-000252

4 Abstract 1438O_PR 'Report on ESMO/SIOPE European Landscape project key results: Mapping the status and needs in AYA cancer care'will be presented by Dr Emmanouil Saloustros during Proffered Paper session on 'Public health policy and health economics' on Monday, 11 September 2017, 16:30 to 18:00 (CEST) in Alicante Auditorium.

5 Abstract 1439O_PR 'Paediatric radiation therapy across Europe - a European questionnaire survey supported by the SIOPE, ESTRO, PROS and several national paediatric hematology-oncology societies (NAPHOS)' will be presented by Dr Charlotte Demoor-Goldschmidt during Proffered Paper session 'Public health policy and health economics' on Monday, 11 September 2017, 16:30 to 18:00 (CEST) in Alicante Auditorium.

6 Abstract 1112PD_PR 'Real-World Productivity, Healthcare Resource Utilization (HRU), and Quality of Life (QOL) in Patients with Advanced Gastric Cancer (GC) in Canada and Europe'will be presented by Mr Gregory Maglinte during Poster Discussion session on Public health policy and health economics on Saturday, 9 September 2017, 16:30 to 17:45 (CEST) in Tarragona Auditorium.

7 Abstract 1541O_PR 'Reproductive potential and performance of fertility-preserving procedures in BRCA mutation-positive (BRCA+) breast cancer (BC) patients (pts)'will be presented by Dr Matteo Lambertini during the Proffered Paper session on 'Supportive and palliative care' on Saturday, 9 September 2017, 16:20 to 18:00 (CEST) in Cordoba Auditorium.

Related Stories

Some stroke survivors may have underlying cancer

September 6, 2017
Some stroke survivors may have underlying cancer, according to an observational study to be presented at the ESMO 2017 Congress in Madrid.

70 percent of advanced cancer patients receive palliative care consultation at ESMO Designated Centres

October 10, 2016
Seven out of 10 patients with advanced cancer receive a palliative care consultation at ESMO Designated Centres of Integrated Oncology and Palliative Care, according to survey results reported today at the ESMO 2016 Congress ...

Lymphoma survivors may not get all recommended follow-up care

January 15, 2016
(HealthDay)—Some teen and young adult survivors of Hodgkin lymphoma do not receive all the recommended follow-up care, a new study finds.

Young adult cancer survivors struggle to get back to normal

July 20, 2017
Cancer survivors often talk about wanting to get back to normal, but a new study indicates many young adults who survived the disease struggle with attaining this goal two years after their initial diagnosis.

Young adults who survive cancer hospitalized more often than the general population

July 13, 2015
Advances in the treatment of adolescents and young adults with cancer have resulted in higher survival rates and longer life expectancies. But up to 20 years after people in the 20-44 age group are declared cancer-free, they ...

Years after diagnosis, many young cancer survivors continue to struggle socially

March 20, 2017
A new study indicates that the social difficulties faced by many adolescent and young adult cancer survivors often persist for years after their diagnosis. Published early online in Cancer, a peer-reviewed journal of the ...

Recommended for you

Research could help fine-tune cancer treatment

May 25, 2018
Cancer therapies that cut off blood supply to a tumour could be more effective in combination with existing chemotherapeutic drugs—according to new research from the University of East Anglia.

Increasing physical activity linked to better immunity in breast cancer patients, study finds

May 25, 2018
A new study from the University of Toronto's Faculty of Kinesiology & Physical Education has found that moderate to vigorous physical activity may help regulate the levels of C-reactive protein – an important biomarker ...

Study finds gut microbiome can control antitumor immune function in liver

May 24, 2018
Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. Their study, published May 25 in Science, was led by researchers in the Center for Cancer Research (CCR) at the National ...

Low-fat diet tied to better breast cancer survival

May 24, 2018
(HealthDay)—Breast cancer patients who adopted a low-fat diet were more likely to survive for at least a decade after diagnosis, compared to patients who ate fattier fare, new research shows.

A cascade of immune processes offers insights to triple-negative breast cancer

May 24, 2018
Cancer is crafty. To survive and thrive, tumors find a way of thwarting our body's natural systems.

By forming clots in tumors, immune cell aids lung cancer's spread

May 24, 2018
University of North Carolina Lineberger Comprehensive Cancer Center researchers have found that by helping to form clots within tumors, immune cells that flock to a particular type of lung cancer are actually building a foundation ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.